These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13933634)

  • 21. [TREATMENT OF HEMOLYTIC DISEASE OF THE NEWBORN].
    LARDINOIS R
    Rev Med Liege; 1963 Oct; 18():648-53. PubMed ID: 14097936
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to Kernicterus.
    HSIA DY; ALLEN FH; GELLIS SS; DIAMOND LK
    N Engl J Med; 1952 Oct; 247(18):668-71. PubMed ID: 12993296
    [No Abstract]   [Full Text] [Related]  

  • 23. [OPTIMUM CONDITIONS FOR EXCHANGE BLOOD TRANSFUSION IN HEMOLYTIC DISEASE OF THE NEWBORN].
    POLACEK K
    Cesk Pediatr; 1963 Jul; 18():577-86. PubMed ID: 14056304
    [No Abstract]   [Full Text] [Related]  

  • 24. [Quantitative relation between direct and indirect bilirubin in the blood of newborn infants and its clinical significance].
    PUNCHENOK NA; SHVARTSVAL'D EP
    Vopr Okhr Materin Det; 1963 Jan; 8():34-8. PubMed ID: 13972530
    [No Abstract]   [Full Text] [Related]  

  • 25. [THE STUDY OF AMNIOTIC BILIRUBIN IN THE PROGNOSIS AND TREATMENT OF FETAL ERYTHROBLASTOSIS CAUSED BY ANTI-RHESUS ISOIMMUNIZATION].
    MAYER M; DUCAS P; LEWI S
    Gynecol Obstet (Paris); 1963; 62():461-504. PubMed ID: 14077900
    [No Abstract]   [Full Text] [Related]  

  • 26. [IS THE CORTICOID THERAPY OF HEMOLYTIC ANEMIA JUSTIFIED?].
    JESCHKEIT G; WEINGAERTNER L
    Kinderarztl Prax; 1963 Jul; 31():317-23. PubMed ID: 14127005
    [No Abstract]   [Full Text] [Related]  

  • 27. [REPEATED EXCHANGE BLOOD TRANSFUSIONS IN THE TREATMENT OF SEVERE FORMS OF FETAL ERYTHROBLASTOSIS].
    BONDAR MV
    Pediatriia; 1964 Mar; 43():27-30. PubMed ID: 14175372
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative spectrophotometic studies of serum and amniotic fluid for the prenatal determination of fetal endangerment in fetal erythroblastosis].
    Reichert K
    Z Geburtshilfe Gynakol; 1967 Dec; 168(1):64-73. PubMed ID: 5595456
    [No Abstract]   [Full Text] [Related]  

  • 29. INDICATIONS FOR EXCHANGE TRANSFUSION BASED UPON THE ROLE OF ALBUMIN IN THE TREATMENT OF HEMOLYTIC DISEASE OF THE NEWBORN.
    WATERS WJ; PORTER E
    Pediatrics; 1964 May; 33():749-57. PubMed ID: 14143273
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies in kernicterus. I. The protein binding of bilirubin.
    ODELL GB
    J Clin Invest; 1959 May; 38(5):823-33. PubMed ID: 13654518
    [No Abstract]   [Full Text] [Related]  

  • 31. THE UNRELIABILITY OF THE TITAN YELLOW METHOD FOR THE DETERMINATION OF MAGNESIUM IN PATIENTS RECEIVING INTRAVENOUS CALCIUM GLUCONATE.
    ANAST CS
    Clin Chem; 1963 Oct; 102():544-51. PubMed ID: 14071653
    [No Abstract]   [Full Text] [Related]  

  • 32. Conjugated serum bilirubin in erythroblastosis fetalis: an analysis of 38 cases.
    HARRIS LE; FARRELL FJ; SHORTER RG; BANNER EA; MATHIESON DR
    Proc Staff Meet Mayo Clin; 1962 Oct; 37():574-81. PubMed ID: 13952939
    [No Abstract]   [Full Text] [Related]  

  • 33. Bilirubin encephalopathy (kernicterus).
    WATERS WJ; RICHERT DA; RAWSON HH
    AMA Am J Dis Child; 1953 Oct; 86(4):483-4. PubMed ID: 13091353
    [No Abstract]   [Full Text] [Related]  

  • 34. [TRANS-ABDOMINAL AMNIOCENTESIS AND SPECTROPHOTOMETRY OF AMNIOTIC FLUID IN FETAL ERYTHROBLASTOSIS].
    PACHI A; POZZI V; DECAMILLIS L; ANGELONI G; D ANTONI L
    Clin Ostet Ginecol; 1964 Dec; 66():740-57. PubMed ID: 14261751
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical application of spectrophotometric determination of bilirubin in the premature and the newborn].
    GEX M; SCHNEEGANS E; HEUMANN G; BEFORT PA; RODIER L
    Pediatrie; 1960; 15():45-55. PubMed ID: 13827697
    [No Abstract]   [Full Text] [Related]  

  • 36. [Determination of hyperbilirubinemia in the newborn using bilirubin curves from infants with hemolytic diseases].
    Arroyo Bornstein A; Manuel Septién J; Crespo Cortina M; Alvarez de los Cobos J; Escalante Vázquez E
    Ginecol Obstet Mex; 1969 May; 24(151):479-87. PubMed ID: 5388424
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors influencing the accumulation of bilirubin in amniotic fluid in Rh hemolytic disease.
    Polácek K; Zwinger A
    Biol Neonate; 1971; 19(4):253-7. PubMed ID: 5169960
    [No Abstract]   [Full Text] [Related]  

  • 38. ADVANCES IN THE HANDLING OF HAEMOLYTIC DISEASE OF THE NEWBORN.
    GROBBELAAR BG; TROTT EL
    S Afr Med J; 1965 Jul; 39():627-30. PubMed ID: 14338515
    [No Abstract]   [Full Text] [Related]  

  • 39. [Contribution of spectrophotometry of amniotic fluid to the prevention of hemolytic disease of the newborn].
    Zwinger A; Vedra B; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):478-81. PubMed ID: 5354331
    [No Abstract]   [Full Text] [Related]  

  • 40. [Critical evaluation of amniotic spectrophotometry with reference to fetal bilirubin metabolism].
    Kopecky P
    Geburtshilfe Frauenheilkd; 1970 Aug; 30(8):745-52. PubMed ID: 5520641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.